Glutathione S-transferase mu, omega, pi, and theta class variants and smoking in Parkinson's disease

Neuroscience Letters

Volumn 413, Issue 3, 2007, Pages 274-278

  Wahner, Angelika D ^a   Glatt, Charles E ^b   Bronstein, Jeff M ^c   Ritz, Beate ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Gene environment interaction; Glutathione S transferase; Parkinson's disease; Smoking

Indexed keywords

GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE MU; GLUTATHIONE TRANSFERASE OMEGA; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE THETA; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CAUCASIAN; DNA POLYMORPHISM; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPROTECTION; PARKINSON DISEASE; PRIORITY JOURNAL; RISK REDUCTION; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, GENETIC; SMOKING;

EID: 33846846680     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.11.053     Document Type: Article

References (31)

1. Baez S., Segura-Aguilar J., Widersten M., Johansson A., and Mannervick B. Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes. Biochem. J. 324 (1997) 25-28
2. Chen C., Liu Q., and Relling M.V. Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks. Pharmacogenetics 6 (1996) 187-191
3. Deng Y., Newman B., Dunne M.P., Silburn P.A., and Mellick G.D. Case-only study of interactions between genetic polymorphisms of GSTM1, P1, T1 and Z1 in smoking in Parkinson's disease. Neurosci. Lett. 366 (2004) 326-331
4. De Palma G., Mozzoni P., Mutti A., Calzetti S., and Negrotti A. Case-control study of interactions between genetic and environmental factors in Parkinson's disease. Lancet 352 (1998) 1986-1987
5. De Simone R., Ajmone-Cat M.A., Carnevale D., and Minghetti L. Activation of alpha7 nicotinic acetylcholine receptor by nicotine selectively up-regulates cycolooxygenase-2 and prostaglandin E2 in rat microglial cultures. J. Neuroinflamm. 2 (2005) 4
6. Entrez Gene (Gene) NCBI Entrez Gene and LocusLink: http://www.ncbi.nlm.nih.gov/Entrez/ http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&DB=gene.
7. Guengerich F., Thier R., Persmark M., Taylor J.B., Pemble S.E., and Ketterer B. Conjugation of carcinogens by theta class glutathione S-transferases: mechanisms and relevance to variations in human risk. Pharmacogenetics 5 (1995) S103-S117
8. Harada S., Fujii C., Hayashi A., and Okoshi N. An association between idiopathic Parkinson's disease and polymorphisms of phase II detoxification enzymes: glutathione S-transferase M1 and quinone oxidoreductase 1 and 2. Biochem. Biophys. Res. Commun. 288 (2001) 887-892
9. Hartmann A., Hunot S., and Hirsch E. Inflammation and dopaminergic neuronal loss in Parkinson's disease: a complex matter. Exp. Neurol. 184 (2003) 561-564
10. Hughes A.J., Ben-Shlomo Y., Daniel S.E., and Lees A.J. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 42 (1992) 1142-1146
11. Hung R., Boffetta P., Brockmoller J., Butkiewicz D., Cascorbi I., and Clapper M.L. CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis. Carcinogenesis 24 (2003) 875-882
12. Kelada S., Kardia S.L.R., Walker A.H., Wein A.J., Malkowicz B., and Rebbeck T.R. The glutathione S-transferase-u and 0 genotypes in the etiology of prostate cancer:genotype-environment interactions with smoking. Cancer Epidemiol. Biomarkers Prev. 9 (2000) 1329-1334
13. Kelada S., Stapleton P.L., Farin F.M., Bammler T.K., Eaton D.L., Smith-Weller T., Franklin G.M., Swanson P.D., Longstreth Jr. W.T., and Checkoway H. Glutathione S-transferase M1, T1, and P1 polymorphisms and Parkinson's disease. Neurosci. Lett. 337 (2003) 5-8
14. Laliberte R., Perregaux D.G., Hoth L.R., Rosner P.J., Jordan C.K., Peese K.M., Eggler J.F., Dombroski M.A., Geoghegan K.F., and Gabel C.A. Glutathione S-transferase omega 1-1 is a target of cytokine release inhibitory drugs and may be responsible for their effect on interleukin-1beta posttranslational processing. J. Biol. Chem. 278 (2003) 16567-16578
15. Li Y.J., Oliveira S.A., Xu P., Martin E.R., Stenger J.E., Scherzer C.R., Hauser M.A., Scott W.K., Small G.W., Nance M.A., Watts R.L., Hubble J.P., Koller W.C., Pahwa R., Stern M.B., Hiner B.C., Jankovic J., Goetz C.G., Mastaglia F., Middleton L.T., Roses A.D., Saunders A.M., Schmechel D.E., Gullans S.R., Haines J.L., Gilbert J.R., Vance J.M., Pericak-Vance M.A., Hulette C., and Welsh-Bohmer K.A. Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease. Hum. Mol. Genet. 12 (2003) 3259-3267
16. Menegon A., Board P.G., Blackburn A.C., Mellick G.D., and Le Couteur D.G. Parkinson's disease, pesticides, and glutathione transferase polymorphisms. Lancet 352 (1998) 1344-1346
17. Miller III M.C., Mohrenweiser H.W., and Bell D.A. Genetic variability in susceptibility and response to toxicants. Toxicol. Lett. 120 (2001) 269-280
18. Morimoto L.M., White E., and Newcomb P.A. Selection bias in the assessment of gene-environment interaction in case control studies. Am. J. Epidemiol. 158 (2003) 259-263
19. Online Mendelian Inheritance in Man, OMIM (June 3, 2006), McKusick-Nathans Institute for Genetic Medicine, Johns Hopkins University (Baltimore, MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD). http://www.ncbi.nlm.nih.gov/omim/ World Wide Web URL:
20. Pemble S., Schroeder K.R., Spencer S.R., Meyer D.J., Hallier E., Bolt H.M., and Ketterer B. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem. J. 300 Pt 1 (1994) 271-276
21. Quik M. Smoking, nicotine, and Parkinson's disease. Trends Neurosci. 27 (2004) 561-568
22. B. Ritz, A. Ascherio, H. Checkoway, K.S. Marder, L.M. Nelson, W.A. Rocca, D. Strickland, S.K. Van Den Eeden, J. Gorell, Pooled analysis of tobacco use and risk of Parkinson's disease, Arch. Neurol., in press.
23. Santt O., Baranova H., Albuisson E., Bignon Y.J., and Lucotte G. Interaction between GSTM1-null and CYP2D6-deficient alleles in the pathogenesis of Parkinson's disease. Eur. J. Neurol. 11 (2004) 247-251
24. Sarkar D., and Fisher P.B. Molecular mechanisms of aging-associated inflammation. Cancer Lett. 236 (2006) 13-23
25. Seidegard J., and Pero R.W. The genetic variation and the expression of human glutathione transferase mu. Klin. Wochenschr. 66 Suppl. 11 (1988) 25-26
26. Tamer L., Ates N.A., Ates C., Ercan B., Elipek T., Yildirim H., Camdeviren H., Atik U., and Aydin S. Glutathione S-transferase M1, T1, and P1 genetic polymorphisms, cigarette smoking and gastric cancer risk. Cell Biochem. Funct. 23 (2005) 267-272
27. Tan E., Khajavi M., Thornby J.I., Nagamitsu S., Jankovic J., and Ashizawa T. Variability and validity of polymorphism association studies in Parkinson's disease. Neurology 55 (2000) 533-538
28. Voho A., Impivaara O., Jarvisalo J., Metsola K., Vainio H., and Hirvonen A. Distribution of glutathione S-transferase M1, P1 and T1 genotypes in different age-groups of Finns without diagnosed cancer. Cancer Detect. Prev. 30 (2006) 144-151
29. Whitbread A., Mellick G.D., Silburn P.A., Le Couteur D.G., and Board P.G. Glutathione transferase omega class polymorphisms in Parkinson disease. Neurology 62 (2004) 1910-1911
30. Whitbread A., Tetlow N., Eyre H.J., Sutherland G.R., and Board P.G. Characterization of the human omega class glutathione transferase genes and associated polymorphisms. Pharmacogenetics 13 (2003) 131-144
31. Ye Z., Song H., Higgins J.P., Pharoah P., and Danesh J. Five glutathione S-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies. PLoS Med. 3 (2006) e91